Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
medicine
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
tc
7eleven
acute migrane
acute myeloid leukemia
alx oncology
artificial intelligence
autoimmune diseases
bain capital
bausch health
berkeley lights
biotech ipos
blu
boston blog main
boston top stories
breast cancer
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
circlek
coronavirus
covid-19
deals
deerfield healthcare technology acquisitions
deerfield management company
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
e-cigarette
e-cigarettes
What
companies
7
×
days
7
×
new
biotech
drug
hasn’t
ipo
ipos
slowed
startups
a.i
accomplish
activity
american
amgen
aren’t
arrival
artificial
astonishing
backed
built
called
capabilities
catching
choose
cig
class
combinator’s
conducted
coronavirus
cost
covid
created
crippling
day
demand
demo
design
diagnose
doctor
Language
unset
Current search:
companies
×
days
×
@techcrunch.com
3 years ago
Y Combinator’s biotech startups incubate a new generation of therapies and tools
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@extremetech.com
4 years ago
NASA JPL Engineers Design COVID-19 Ventilator in 37 Days
@xconomy.com
5 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@engadget.com
6 years ago
E-cig makers have 60 days to show they aren’t targeting minors
@techcrunch.com
7 years ago
Remedy is a Khosla-backed teledoc with A.I. capabilities for the uninsured
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines